Featured
Dual Therapy Shifts SMA Treatment Landscape
Trial Briefs Sep 4, 2026
Trial Briefs Sep 3, 2026
Trial Briefs Sep 2, 2026
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam...
Read our latest Drug Approvals articles.
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or clopidogrel.
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.
New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...
Researchers develop toolkit to address policymaking privilege disparities and inequities in public policy decisions.
Architects of the hunt design deadly strategies in media regulation. Sign the open letter calling for a public inquiry into...
Republican lawmakers vote to hold Fauci in contempt of Congress over COVID-19 pandemic handling disputes, escalating political tensions.
Greens Senator introduces bill to change assisted dying law to allow telehealth access, improving access for medically supported voluntary assisted...
Australia cannot afford business as usual amid Northern Hemisphere fires, as global climate crises intensify. Learn how these events affect...
Trump’s vaccine policy sparks nationwide debate over parental choice and public health risks amid reduced childhood vaccine recommendations.
Australia’s new health safety standards may overlook critical communication risks for deaf patients, leaving them at risk. Share your feedback...